The health insurer's third-quarter adjusted earnings of 96 cents a share beat analysts' estimates by 1 cent.

The stock is cut to hold from buy as analyst David Windley sees political risk remaining for at least nine months.

Medical healthcare plan provider Centene reports second-quarter results that exceed analysts' forecasts amid higher sales of its Medicaid health plans for low-income earners, and lifts its 2019 guidance.

Centene shares are falling sharply after Humana says it won't place a bid for the health insurer.

This IPO scenario is playing out as Jim Cramer predicted. He says big funds are selling their high-growth technology stocks to raise money to buy the coming onslaught of offerings.

Stocks fall Wednesday as investors weigh a narrowing of the U.S. trade deficit against worries about a recession in the U.S. and possible delays in U.S.-China trade talks.

CVS shares fall as investors see tougher competition, particularly in its healthcare services business, following the announcement of Centene's plans to buy WellCare.

Centene will acquire smaller rival WellCare Health Plans in a transaction with a total enterprise value of $17.3 billion.

U.S. stock futures turn lower as investors track moves in the bond market; the ITC rules against banning imports of some of Apple iPhones linked to a complicated patent dispute with Qualcomm; Centene to buy smaller rival WellCare.

People who are traveling by air are about to see a change in recent trends.

Beverage giant is rolling out a new taste in its efforts to attract and keep a key demographic.

You can find savings on everything from EVs to solar panels in the Inflation Reduction Act.